Phase II study of sunitinib as second-line treatment for advanced gastric cancer
2010 · Investigational New Drugs · 193 citations
https://doi.org/10.1007/s10637-010-9438-y
W
Wai Tong Ng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
276
Papers
11.8K
Citations
55
h-index
131
i10-index
Wai Tong Ng is an academic researcher from Chinese University of Hong Kong. The author has contributed to research in topics: Head and Neck Cancer Studies & Head and Neck Surgical Oncology & Lung Cancer Treatments and Mutations. The author has an h-index of 55, co-authored 235 publications.
ORCID: 0000-0001-6696-3000Papers by this author
worksInternational Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
2021 · International Journal of Radiation Oncology*Biology*Physics · 96 citations
https://doi.org/10.1016/j.ijrobp.2021.01.041
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis
2023 · The Lancet Oncology · 58 citations
https://doi.org/10.1016/s1470-2045(23)00163-8
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis
2023 · The Lancet Oncology · 58 citations
https://doi.org/10.1016/s1470-2045(23)00163-8
Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma
2022 · EBioMedicine · 55 citations
https://doi.org/10.1016/j.ebiom.2022.104357
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
2021 · Clinical and Translational Radiation Oncology · 44 citations
https://doi.org/10.1016/j.ctro.2021.11.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat